Published in Medicine and Law Weekly, August 25th, 2006
Study 1: HAART susceptibilities were determined for HIV-1 non-B subtypes.
According to recent research from France, "Most studies on antiretroviral (ARV) resistance of human immunodeficiency virus (HIV) have been done on subtype B which only represent a limited proportion of infections worldwide." A study was conducted to understand "baseline susceptibilities to ARVs in non-B strains."
"To explore in greater detail possible intrinsic resistance to antiretroviral drugs in non-B subtypes, phenotypic resistance was tested in 35 non-B (A, D, F. G. J;...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.